ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESR01

Oral BCG: Optimizing mucosal vaccination against tuberculosis

Active
Institution
UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA
Principal investigator
Philana Ling Lin
Funding
$1.2M
Duration
2025–2030
Open portfolio

Moonbase score

Still being scored

Abstract

Tuberculosis is the second most common cause of infectious death worldwide and preventative efforts to develop a highly effective vaccine have been unsuccessful thus far. BCG (Bacille- Calmette-Guerin) vaccination remains the most widely available vaccine against TB, reducing severe disease in neonates, though its efficacy is only 50% for all forms of TB. We have shown that changing the route of BCG administration profoundly influences its protective efficacy. In the macaque model of TB, intravenous BCG provided 90% protection against Mtb challenge. Oral BCG was the first human vaccine given in infants against TB with good historical safety and efficacy. Here, we propose to optimize an oral BCG regimen (Aim 1), compare the efficacy of oral BCG to intravenous and intra-dermal BCG (current human standard) against Mtb challenge using modern imaging, immunologic (innate and adaptive lymphocyte function, systems serology, scRNA-seq) and molecular tools (Aim 2). Lastly, we will use computational systems modeling to identify correlates of vaccine-induced protection against Mtb infection (Aim 3). Data in this proposal will provide critical information about the efficacy of oral BCG and discover important measures that correlate with vaccine induced protection and failure. If successful, such measures could transform the TB field.

Research team

  • Joanne L. FlynnPI
  • Sarah FortunePI
  • Philana Ling LinPI

LOADING MOONBASE SCORE

R01NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESVaccines Against Infectious Diseases Study Section[VID]tuberculosisintravenousprotectionvaccinationvaccinebcgmtboral

Questions for UNIVERSITY OF PITTSBURGH AT PITTSBURGH

Answered by the team behind this research.

No questions yet. Sign in to ask the first one

Related grants

Same researchers, same institution, same topic, scored first.